San Diego medical device maker ResMed Inc. reported net income of $90.5 million for the second quarter of fiscal 2016, down 1 percent from the same quarter the previous year.
Revenue was up 7 percent to $454.5 million, compared with $422.9 million in the second quarter of the previous year.
Cash flow from operations for the quarter was $147.4 million.
ResMed stock is currently trading on the New York Stock Exchange under the stock symbol RMD for $54.04 per share.
- Advertisement -
